NCT04352270 (AD-TPE) is a NA clinical trial of AD printed educational materials in Atopic Dermatitis, sponsored by Boston University.

Who is sponsoring NCT04352270?

NCT04352270 is sponsored by Boston University.

What drugs are being tested in NCT04352270?

Interventions in NCT04352270: AD printed educational materials, AD educational videos.

What condition does NCT04352270 study?

NCT04352270 studies Atopic Dermatitis.

Is NCT04352270 still recruiting?

NCT04352270 is currently completed. Last updated 5 March 2024.

Last reviewed 2024-03-05 · How we verify

NCT04352270: AD-TPE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinic-Based Atopic Dermatitis Therapeutic Patient Education

Completed NA Last updated 5 March 2024

What this trial tests

NA trial testing AD printed educational materials in Atopic Dermatitis in 56 participants. Completed in 21 September 2023.

Timeline

27 February 2023

Primary endpoint
21 September 2023

21 September 2023

Quick facts

Lead sponsor	Boston University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	56
Start date	27 February 2023
Primary completion	21 September 2023
Estimated completion	21 September 2023
Sites	1 location across United States

Drugs / interventions tested

AD printed educational materials
AD educational videos

Conditions studied

Atopic Dermatitis — all drugs for Atopic Dermatitis →

Sponsor

Boston University

Who can join

Under 17, any sex, with Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this randomized trial is to determine whether comprehensive, accessible, and animation-style videos are a more effective method of therapeutic patient education (TPE) based on clinical outcomes than paper handouts in Spanish and English-speaking communities. The clinical outcomes being measured are the severity, sleep affected by atopic dermatitis (AD), and the amount of itch experienced.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Educational and psychological interventions for managing atopic dermatitis (eczema).
Singleton H, Hodder A, Almilaji O, Ersser SJ, et al · · 2024 · cited 14× · PMID 39132734 · DOI 10.1002/14651858.cd014932.pub2

Verify or expand the search:

Other recruiting trials for Atopic Dermatitis

Currently open trials in the same condition.

NCT07262983 — Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi · Phase 1 · recruiting
NCT07445919 — A Clinical Study to Evaluate SM17 for Atopic Dermatitis · Phase 2 · recruiting
NCT07488065 — A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants · Phase 1 · recruiting
NCT07467564 — The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatit · recruiting
NCT07358156 — A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and E · Phase 1 · recruiting

Other Boston University trials

Trials by the same sponsor.

NCT07199634 — Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0) · NA · not yet recruiting
NCT05838378 — Cigarillo Warnings Image Sorting Study · NA · completed
NCT06088277 — Texting to Reduce Human Immunodeficiency Virus (HIV) Risk · NA · recruiting
NCT06455111 — Evaluation of an Artificial Intelligence-Assisted, Image-Based Dietary Assessment Tool in the Framingham Heart Study · NA · completed
NCT06003439 — Vaping Prevention and Vaping in Youth (Vapechat) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04352270 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston University
Last refreshed: 5 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04352270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing